
Sign up to save your podcasts
Or


Bacterial resistance to antibiotics kills between 1.25-5 million people every year. So why is antimicrobial resistance (AMR) not given the priority or funding that some other health problems receive?
We hear from Christopher Murray, director of the Institute for Health Metrics and Evaluation which has done the first global assessment of the impact of AMR, and UK AMR envoy Sally Davies, who says AMR needs to be treated as a pandemic.
By World Economic Forum2.8
6464 ratings
Bacterial resistance to antibiotics kills between 1.25-5 million people every year. So why is antimicrobial resistance (AMR) not given the priority or funding that some other health problems receive?
We hear from Christopher Murray, director of the Institute for Health Metrics and Evaluation which has done the first global assessment of the impact of AMR, and UK AMR envoy Sally Davies, who says AMR needs to be treated as a pandemic.

776 Listeners

380 Listeners

1,803 Listeners

268 Listeners

1,095 Listeners

500 Listeners

162 Listeners

104 Listeners

212 Listeners

98 Listeners

614 Listeners

100 Listeners

16 Listeners

172 Listeners

225 Listeners

61 Listeners

190 Listeners

23 Listeners

219 Listeners